Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable ...

The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...

This is eight fewer than the FDA, which approved 46 novel drugs in 2025 – sneaking in two regulatory decisions during the ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

The FDA has granted full approval to verdinexor tablets (Laverdia; Anivive Lifesciences) for the treatment of dogs with lymphoma. The approval gives veterinarians a promising new oral avenue for ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of Gazyva for lupus nephritis.

Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and ...

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...